-
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Recommendation of "Buy" from Analysts
Source: Buzz FX / 03 Feb 2025 03:31:09 America/Chicago
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Average Recommendation of "Buy" from Analysts Written by MarketBeat February 3, 2025 Share Link copied to clipboard. Shares of Mirum Pharmaceuticals, Inc.
Read more...